炎症性肠病队列中的脊柱关节炎:系统文献综述与研究设计批判性评价
该系统文献综述检索了PubMed、Ovid、Scopus、Cinahl、Medline、Web of Science和Cochrane数据库,纳入2000年1月至2020年3月发表的69项评估炎症性肠病患者肌肉骨骼疾病患病率/发病率的研究。中轴型脊柱关节炎中位患病率为5%(范围1%-46%),外周型为16%(范围1%-43%);多数研究为门诊来源(54/69,78%)、单中心(47/69,68%)和横断面设计(60/69,87%)。作者认为炎症性肠病患者的脊柱关节炎表型谱仍未被充分描述,未来研究应聚焦于标准化变量收集和定义肌肉骨骼表型。
要点
- 炎症性肠病队列中中轴型脊柱关节炎中位患病率为5%(范围1%-46%)。
- 炎症性肠病队列中外周型脊柱关节炎中位患病率为16%(范围1%-43%)。
- 69项研究中54项(78%)为门诊来源、47项(68%)为单中心、60项(87%)为横断面设计。
核心结论
- 炎症性肠病患者中脊柱关节炎表型谱仍未被充分描述。
- 未来研究应聚焦于标准化炎症性肠病-脊柱关节炎队列中收集的变量,并定义炎症性肠病-脊柱关节炎中的肌肉骨骼表型,以更好地描述该疾病实体并推动临床和研究领域发展。
研究设计与样本
- 系统文献综述,检索PubMed、Ovid、Scopus、Cinahl、Medline、Web of Science和Cochrane数据库。
- 纳入2000年1月至2020年3月发表的、评估炎症性肠病患者队列中肌肉骨骼疾病患病率/发病率的研究。
- 共纳入69项研究。
主要发现
- 69项研究中,54项(78%)为门诊来源,47项(68%)为单中心,60项(87%)为横断面设计。
- 炎症性肠病中中轴型脊柱关节炎中位患病率为5%(范围1%-46%),外周型脊柱关节炎中位患病率为16%(范围1%-43%)。
- 在38项前瞻性纳入患者并评估中轴疾病的研究中,53%分析了炎性背痛,68%使用了脊柱关节炎分类标准,76%进行了影像学检查。
- 在35项前瞻性纳入患者并评估外周疾病的研究中,46%使用了脊柱关节炎分类标准,74%进行了体格检查,而在进行体格检查的研究中54%由风湿科医生完成。
- 外周型脊柱关节炎的亚表型(单关节炎或少关节炎、多关节炎、附着点炎、指趾炎)报告不一致;74%的研究未提及是否评估或排除了骨关节炎和纤维肌痛。
关键数值与推荐
- 中轴型脊柱关节炎中位患病率5%(范围1%-46%),外周型脊柱关节炎中位患病率16%(范围1%-43%)。
- 38项前瞻性评估中轴疾病的研究中,53%分析了炎性背痛,68%使用了脊柱关节炎分类标准,76%进行了影像学检查。
- 35项前瞻性评估外周疾病的研究中,46%使用了脊柱关节炎分类标准,74%进行了体格检查,其中54%由风湿科医生完成体格检查。
- 74%的研究未提及是否评估或排除了骨关节炎和纤维肌痛。
临床怎么用
- 原文未据此给出推荐。
局限性
- 大多数纳入研究为门诊来源(54/69,78%)、单中心(47/69,68%)和横断面设计(60/69,87%)。
- 外周型脊柱关节炎亚表型(单关节炎或少关节炎、多关节炎、附着点炎、指趾炎)报告不一致。
- 74%的研究未提及是否评估或排除了骨关节炎和纤维肌痛。
- 炎症性肠病患者中脊柱关节炎表型谱仍未被充分描述。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To critically appraise study designs evaluating spondyloarthritis (SpA) phenotypes in patients with inflammatory bowel disease (IBD). A systematic literature review of PubMed, Ovid, Scopus, Cinahl, Medline, Web of Science, and Cochrane databases was performed. Articles published from January 2000 - March 2020 were included if they evaluated the prevalence/incidence of musculoskeletal disease in cohorts of IBD patients. Most of the 69 included studies were clinic based (54/69, 78%), single center (47/69, 68%) and cross-sectional (60/69, 87%). The median prevalence of axial and peripheral SpA in IBD was 5% (range 1 - 46%) and 16% (range 1 - 43%), respectively. In 38 studies that evaluated axial disease in prospectively enrolled patients, inflammatory back pain was analyzed in 53%. SpA classification criteria were used in 68% and imaging was performed in 76%. In 35 studies that evaluated peripheral disease in prospectively enrolled patients, SpA classification criteria were used in 46%. A physical exam was performed in 74%, and it was performed by a rheumatologist in 54% of studies with a physical exam. Sub-phenotypes of peripheral SpA (mono- or oligo-arthritis, polyarthritis, enthesitis, dactylitis) were variably reported. Seventy-four percent of studies did not mention whether osteoarthritis and fibromyalgia had been assessed or excluded. The spectrum of SpA phenotypes in IBD patients remains incompletely characterized. Future studies should focus on standardizing the variables collected in IBD-SpA cohorts and defining musculoskeletal phenotypes in IBD-SpA in order to better characterize this disease entity and advance the field for clinical and research purposes.
引用
- Schwartzman M, Ermann J, Kuhn KA, et al. Spondyloarthritis in inflammatory bowel disease cohorts: systematic literature review and critical appraisal of study designs. RMD Open. 2022. PMID: 35046098. doi:10.1136/rmdopen-2021-001777
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。